• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ST. WENDEL AG ULTRAFLUX EMIC2; SET, TUBING, BLOOD, WITH AND WITHOUT ANTI-REGURGITATION VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ST. WENDEL AG ULTRAFLUX EMIC2; SET, TUBING, BLOOD, WITH AND WITHOUT ANTI-REGURGITATION VALVE Back to Search Results
Catalog Number 01-9771-0
Device Problem Fluid/Blood Leak (1250)
Patient Problem Hemorrhage/Bleeding (1888)
Event Date 01/03/2024
Event Type  malfunction  
Event Description
It was reported that a dialyzer blood leak occurred during a patient¿s continuous renal replacement therapy (crrt).The dialysis machine alarmed with a presence of bubbles near the venous bubble trap alarm, however there were no visible bubbles.The patient was disconnected and the catheter secure.A white filament from the venous line was removed.The filament resembled a polymer that could possibly be a part of the dialysis kit membrane.The patient disconnection without restitution and treatment was reset up with another kit.Treatment was interrupted for one hour that resulted in approximately 200 ml of blood loss.The sample was not available to be returned for evaluation.Additional information requested but has not been obtained.
 
Manufacturer Narrative
The plant investigation is in process.A supplemental mdr will be submitted upon completion of this activity. .
 
Manufacturer Narrative
Investigation: the complaint sample was received for visual examination.Visual examination confirmed the reported failure.The reported event is adequately addressed in the instructions for use.It is manufactured under well controlled environmental conditions.The analysis of the foreign body showed that it is biological material and that it could not have been introduced during production.The device history record review indicated that there was no indication for any relationship with the reported failure mode has been found during review.Complaint history reviewed indicated that there is no other complaint regarding this lot.The reported event is covered in the risk analysis.
 
Event Description
It was reported that a dialyzer blood leak occurred during a patient¿s continuous renal replacement therapy (crrt).The dialysis machine alarmed with a presence of bubbles near the venous bubble trap alarm, however there were no visible bubbles.The patient was disconnected and the catheter secure.A white filament from the venous line was removed.The filament resembled a polymer that could possibly be a part of the dialysis kit membrane.The patient disconnection without restitution and treatment was reset up with another kit.Treatment was interrupted for one hour that resulted in approximately 200 ml of blood loss.The sample was not available to be returned for evaluation.Additional information requested but has not been obtained.
 
Manufacturer Narrative
Additional information provided in h6 and h10.Investigation: the complaint sample was received for visual examination.Visual examination did not confirm the reported failure.The reported event is adequately addressed in the instructions for use and/or on the label and the product deficiency is not related to falsification.The analysis of the foreign body showed that it is biological material and it is not a polymer.The white strips may be protein deposits caused by clogging.An insertion about production is to be excluded.It is manufactured under well controlled environmental conditions.Therefore, it is assumed that no foreign bodies are present and that any residues of the composition will not cause chemical/physical harm to the patient.The device history record review indicated that there was no indication for any relationship with the reported failure mode has been found during review.Complaint history reviewed indicated that there is one other complaint regarding this lot.The reported event is covered in the risk analysis.The reported event is not confirmed as the product functioned as intended.
 
Event Description
It was reported that a dialyzer blood leak occurred during a patient¿s continuous renal replacement therapy (crrt).The dialysis machine alarmed with a presence of bubbles near the venous bubble trap alarm, however there were no visible bubbles.The patient was disconnected and the catheter secure.A white filament from the venous line was removed.The filament resembled a polymer that could possibly be a part of the dialysis kit membrane.The patient disconnection without restitution and treatment was reset up with another kit.Treatment was interrupted for one hour that resulted in approximately 200 ml of blood loss.The sample was not available to be returned for evaluation.Additional information requested but has not been obtained.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ULTRAFLUX EMIC2
Type of Device
SET, TUBING, BLOOD, WITH AND WITHOUT ANTI-REGURGITATION VALVE
Manufacturer (Section D)
ST. WENDEL AG
frankfurter str. 6-8
st. wendel 66606
GM  66606
Manufacturer (Section G)
ST. WENDEL AG
frankfurter str. 6-8
st. wendel 66606
GM   66606
Manufacturer Contact
jessica trujillo
920 winter st
waltham, MA 02451
6174175172
MDR Report Key18573340
MDR Text Key333624550
Report Number3002807005-2024-00001
Device Sequence Number1
Product Code FJK
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
EUA200149
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Pharmacist
Type of Report Initial,Followup,Followup
Report Date 05/02/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number01-9771-0
Device Lot NumberE2BA10100
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Device AgeMO
Initial Date Manufacturer Received 01/04/2024
Initial Date FDA Received01/24/2024
Supplement Dates Manufacturer Received04/22/2024
04/30/2024
Supplement Dates FDA Received05/02/2024
05/02/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-